Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Inspire Veterinary Partners Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Inspire Veterinary Partners Inc (IVP) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
6.60 %
Q3 2025
Net Margin
-58.53 %
Q3 2025

Key Findings: Inspire Veterinary Partners Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 15M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+12.7% annualized vs trailing 12 months).
  • Peer revenue share: Inspire Veterinary Partners Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

IVP Sales vs. its Competitors, Q3 2025

Inspire Veterinary Partners Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/IVP/competitors
https://api.csimarket.com/api/v1/companies/IVP/relationships
https://api.csimarket.com/api/v1/companies/IVP/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Agricultural Production industry grew revenue 16.8% year over year, combined, vs 6.6% for Inspire Veterinary Partners Inc. Inspire Veterinary Partners Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Inspire Veterinary Partners Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Inspire Veterinary Partners Inc No No No Yes
High-Confidence Competitors (2) 100% 100% 100% 50%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q3 2025

100%market share
  • Inspire Veterinary Partners Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Inspire Veterinary Partners Inc and its 0 tracked competitors.

See Inspire Veterinary Partners Inc's full market share breakdown »

IVP Stock Performance relative to its Competitors

IVP Competitors (weighted) Percent change over the selected range

Inspire Veterinary Partners Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 1)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Inspire Veterinary Partners Inc -99.20 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Inspire Veterinary Partners Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

IVP Stock Performance relative to High-Confidence Competitors

IVP High-Confidence Competitors (equal-weighted, 4) Percent change over the selected range

Inspire Veterinary Partners Inc's Comment on Competition and Industry Peers

As of early 2022, the U.S. veterinary industry comprises approximately 13 national consolidators and 30 regional consolidators operating around 6,000 of nearly 30,000 veterinary hospitals. Major competitors include Mars and NVA, which together own about 4,000 hospitals, along with Pathway/Thrive, VetcCor, Southern Vet Partners, and Community Veterinary Partners. Industry growth has been driven by mid-sized and small platforms acquiring hospitals to expand to 50-200 units, while larger groups have absorbed competitors, such as Pathway's acquisition of Thrive and NVA's acquisition of Compassion First. Competitors leverage brand awareness, financial resources, and infrastructure. The company seeks to differentiate itself through a broad employee equity offering, personalized hospital integration, customized coaching workflows, and disciplined acquisition strategies focused on profitable locations.

Inspire Veterinary Partners Inc's Competitors Named by the Company

Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Thrive Named by the company 85% 2022 to 2026 3
NVA Named by the company 85% 2022 to 2026 3
VetcCor Named by the company 85% 2022 to 2026 3
Compassion First Named by the company 85% 2022 to 2026 3
Southern Vet Partners Named by the company 85% 2022 to 2026 3
Pathway Named by the company 85% 2022 to 2026 3
Vetspire Practice Named by the company 85% 2022 to 2026 3
Mars Named by the company 85% 2022 to 2026 3
Thrive Named by the company 85% 2022 to 2026 3
Community Veterinary Partners Named by the company 85% 2022 to 2026 3
Pathway/Thrive Named by the company 85% 2022 to 2026 3
Competitor Evidence Detail

Filing basis, confidence, active dates and source counts for Inspire Veterinary Partners Inc's named competitors require a Commercial License.

Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.